HarmonyCA™

HARmonyCa™ with Lidocaine, Allergan Aesthetics' first dual-effect injectable, addresses the demand for increasingly sophisticated non-surgical aesthetic treatments.

HarmonyCa™ with Lidocaine aims to respond to the multidimensional needs of aging of the face in a way that most single agents cannot 1-6

As a new generation collagen biostimulator, it combines hyaluronic acid (HA) and calcium hydroxyapatite (CaHA) in a single injection without the need for reconstitution, 7 for an immediate lifting effect, provided by HA, and a sustained stimulation of collagen. offered by CaHA. 8.9

References:

1. Kahn DM and Shaw RB. Facial Plast Surg. 2010;26(5):350–55.

2. Swift A et al. Aesthet Surg J. 2021;41(10):1107–19.

3. Coleman SR and Grover R. Aesthet Surg J. 2006;26(1S):S4–9.

4. Sanchez-Carpintero I et al. Dermosifiliogr. 2010;101(5):381–93.

5. Gonzaga da Cunha M et al. Surg Cosmet Dermatol. 2020;12(2):109–17.

6. Hee C et al. Dermatol Surg. 2015;41(Suppl 1):S373–81.

7. Allergan Aesthetics. HarmonyCa™ Lidocaine IFU. M032 V01. 2021.

8. Allergan Aesthetics. Data on File. HarmonyCaTM Lidocaine INT-HAR-2150036. Lift capacity. July 2021.

9. Allergan Aesthetics. Data on File. HarmonyCaTM Lidocaine INT-HAR-2150040. Collagen stimulation. July 2021.